Literature DB >> 20414675

Nonconventional papillary thyroid carcinomas with pleomorphic tumor giant cells: a diagnostic pitfall with anaplastic carcinoma.

Juliette Hommell-Fontaine1, Angela Borda, Florence Ragage, Nicole Berger, Myriam Decaussin-Petrucci.   

Abstract

The presence of pleomorphic tumor giant cells in thyroid carcinomas of follicular cell origin is always worrisome for the pathologist as they first of all refer to anaplastic carcinoma, one of the most aggressive human malignancies. However, non-anaplastic pleomorphic giant cells are well described in other thyroid diseases, most often benign. In this paper, we describe four cases of papillary thyroid carcinoma displaying pleomorphic tumor giant cells with features that differ from those of anaplastic carcinoma. Pleomorphic giant cells were admixed with the underlying thyroid carcinoma and constituted from 5% to 25% of the tumor. Cytologically, they had an abundant eosinophilic cytoplasm with large and irregular nuclei. Compared to pleomorphic giant cells of anaplastic carcinoma, they reproduced the growth pattern of the underlying carcinoma, had a low mitotic index without necrosis or inflammation, and were reactive with thyroglobulin and thyroid-specific transcription factor-1 and strongly and diffusely positive for cytokeratin AE1/AE3. After 16-84 months of follow-up, patients are relapse-free and still alive. These cases show that pleomorphic tumor giant cells arising in papillary thyroid carcinomas do not always represent dedifferentiation and progression to anaplastic carcinoma. Distinction among these processes is critical as their treatment and prognosis are very different.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20414675     DOI: 10.1007/s00428-010-0919-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  43 in total

1.  Medullary carcinoma of the thyroid. Giant cell type.

Authors:  K Kakudo; A Miyauchi; T Ogihara; S I Takai; H Kitamura; G Kosaki; Y Kumahara
Journal:  Arch Pathol Lab Med       Date:  1978-09       Impact factor: 5.534

Review 2.  Histological alterations following thyroid fine needle biopsy: a systematic review.

Authors:  Stergios A Polyzos; Kalliopi Patsiaoura; Konstantia Zachou
Journal:  Diagn Cytopathol       Date:  2009-06       Impact factor: 1.582

3.  Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy.

Authors:  P S de Matos; A P Ferreira; F de Oliveira Facuri; L V M Assumpção; K Metze; L S Ward
Journal:  Histopathology       Date:  2005-10       Impact factor: 5.087

Review 4.  Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas.

Authors:  Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

5.  Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases.

Authors:  Y S Venkatesh; N G Ordonez; P N Schultz; R C Hickey; H Goepfert; N A Samaan
Journal:  Cancer       Date:  1990-07-15       Impact factor: 6.860

6.  Cytologic findings in thyroid nodules after 131I treatment of hyperthyroidism.

Authors:  S R Granter; E S Cibas
Journal:  Am J Clin Pathol       Date:  1997-01       Impact factor: 2.493

7.  Bizarre leiomyomas of the uterus: a comprehensive pathologic study of 24 cases with long-term follow-up.

Authors:  K A Downes; W R Hart
Journal:  Am J Surg Pathol       Date:  1997-11       Impact factor: 6.394

8.  Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid.

Authors:  P Soares; J Cameselle-Teijeiro; M Sobrinho-Simões
Journal:  Histopathology       Date:  1994-03       Impact factor: 5.087

9.  Anaplastic thyroid carcinoma: risk factors and outcome.

Authors:  J G Demeter; S A De Jong; A M Lawrence; E Paloyan
Journal:  Surgery       Date:  1991-12       Impact factor: 3.982

10.  HBME-1 immunostaining in thyroid tumors especially in follicular neoplasm.

Authors:  Takahiro Mase; Hiroomi Funahashi; Takashi Koshikawa; Tsuneo Imai; Yoshiharu Nara; Yuji Tanaka; Akimasa Nakao
Journal:  Endocr J       Date:  2003-04       Impact factor: 2.349

View more
  1 in total

1.  Papillary thyroid carcinoma with pleomorphic tumor giant cells in a pregnant woman - a case report.

Authors:  Johan O Paulsson; Jan Zedenius; C Christofer Juhlin
Journal:  BMC Endocr Disord       Date:  2018-07-05       Impact factor: 2.763

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.